ليست عنوان مقالات لاتين Coronary artery bypass grafting in the elderly Corporate mandatory disclosure practices in Bangladesh

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Coronary artery bypass grafting in the elderly

2

Coronary artery bypass grafting in type II diabetic patients: a comparison between insulin-dependent and non-insulin-dependent patients at short- and mid-term follow-up

3

Coronary Artery Bypass Grafting is Associated With Excellent Long-Term Survival and Quality of Life: A Prospective Cohort Study

4

Coronary Artery Bypass Grafting is Still the Best Treatment for Multivessel and Left Main Disease, But Patients Need to Know

5

Coronary Artery Bypass Grafting is Superior to Percutaneous Coronary Intervention in Prevention of Perioperative Myocardial Infarctions During Subsequent Vascular Surgery

6

Coronary artery bypass grafting on the beating heart: a simple technique for subluxating the heart

7

Coronary Artery Bypass Grafting Using an Abdominal Artery as an Inflow

8

Coronary artery bypass grafting using the gastroepiploic artery in 1,000 patients

9

Coronary artery bypass grafting using the radial artery: midterm results in a Japanese institute

10

Coronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy

11

Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation for Left Main Coronary Artery Disease (from a Two-Center Registry)

12

Coronary artery bypass grafting with an expanded polytetrafluoroethylene graft

13

Coronary artery bypass grafting with cardiopulmonary bypass versus off-pump cardiopulmonary bypass grafting: does eliminating the pump reduce morbidity and cost?

14

Coronary artery bypass grafting with gastroepiploic artery composite graft

15

Coronary artery bypass grafting with left internal mammary artery and right gastroepiploic artery, with and without bypass

16

Coronary Artery Bypass Grafting With Single Cross-Clamp Results in Fewer Persistent Neuropsychological Deficits Than Multiple Clamp or Off-Pump Coronary Artery Bypass Grafting

17

Coronary artery bypass grafting within 30 days of an acute myocardial infarction

18

Coronary artery bypass grafting without cardiopulmonary bypass

19

Coronary artery bypass grafting without cardiopulmonary bypass

20

Coronary artery bypass grafting without cardiopulmonary bypass and without interruption of native coronary flow using novel anastomosis site restraining device (“Octopus”)

21

Coronary artery bypass grafting without cardiopulmonary bypass through sternotomy and minimally invasive procedure

22

Coronary Artery Bypass Grafting: A Precipitating Factor for Perioperative Diabetic Ketoacidosis

23

Coronary Artery Bypass Grafting: Long-Term Psychological and Social Outcomes

24

Coronary artery bypass in patients 80 years and over: is off-pump the operation of choice?

25

Coronary Artery Bypass is Superior to Drug-Eluting Stents in Multivessel Coronary Artery Disease

26

Coronary artery bypass operation after pneumonectomy

27

Coronary Artery Bypass Risk Prediction Using Neural Networks

28

Coronary Artery Bypass Surgery and Acute Kidney Injury: Impact of the Off-Pump Technique

29

Coronary artery bypass surgery by the transdiaphragmatic approach

30

Coronary Artery Bypass Surgery in Coronary Artery Disease Concomitant with Porcelain Aorta: Great Challenge for Cardiac surgeon

31

Coronary artery bypass surgery in octogenarians: outcomes in a tertiary referral university hospital in a developing country

32

Coronary artery bypass surgery in patients with severe left ventricular dysfunction

33

Coronary artery bypass surgery is still cost-effective: using calibrated models toupdate clinical trials

34

Coronary artery bypass surgery or percutaneous coronary intervention after fibrinolysis: A critical reappraisal

35

Coronary Artery Bypass Surgery versus Medical Treatment in Patients with Low Ejection Fraction and Coronary Artery Disease

36

Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial

37

Coronary artery bypass surgery: Why donʹt the wealthy choose the best hospitals?

38

Coronary artery bypass via diaphragmatic approach with free graft

39

Coronary artery bypass: a userʹs manual

40

Coronary artery calcification and cardiovascular risk factors: impact of the analytic approach

41

Coronary Artery Calcification and Changes in Atheroma Burden in Response to Established Medical Therapies Original Research Article

42

Coronary Artery Calcification and Myocardial Perfusion in Asymptomatic Adults: The MESA (Multi-Ethnic Study of Atherosclerosis) Original Research Article

43

Coronary Artery Calcification and Myocardial Perfusion: Kissing Cousins or Distant Relatives?

44

Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism

45

Coronary artery calcification in black women and white women

46

Coronary artery calcification is related to functional polymorphism of matrix metalloproteinase 3: the Helsinki Sudden Death Study

47

Coronary artery calcification on computed tomography

48

Coronary artery calcification on computed tomography

49

Coronary artery calcification on computed tomography

50

Coronary artery calcification on computed tomography

51

Coronary artery calcification screening to rule out acute myocardial infarction prior to hospital admission

52

Coronary Artery Calcification, an Improvement in Risk Classification: Need for Reappraisal?

53

Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors

54

Coronary artery calcification: “...empty your cup...”, ,

55

Coronary Artery Calcification: Pathogenesis and Prognostic Implications

56

Coronary artery calcifications in the long-term follow-up of Kawasaki disease

57

Coronary artery calcium (CAC) score – a prognostic tool in coronary artery disease

58

Coronary Artery Calcium and Risk of Atrial Fibrillation (from the Multi-Ethnic Study of Atherosclerosis)

59

Coronary artery calcium as a measure of biologic age

60

Coronary Artery Calcium Detected by Digital Fluoroscopy and Risk Factors in Healthy Subjects

61

Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events

62

Coronary Artery Calcium Progression: An Important Clinical Measurement?: A Review of Published Reports

63

Coronary artery calcium scanning: Clinical paradigms for cardiac risk assessment and treatment

64

Coronary Artery Calcium Score Assessment in Breast Cancer Patients After Three-Dimensional Conformal Radiotherapy: Is Calcium Score an Appropriate Screening Study?

65

Coronary artery calcium score, risk factors, and incident coronary heart disease events

66

Coronary Artery Calcium Score: A Review

67

Coronary Artery Calcium to Predict All-Cause Mortality in Elderly Men and Women Original Research Article

68

Coronary Artery Calcium Versus Intima-Media Thickness as a Measure of Cardiovascular Disease Among Asymptomatic Adults (from The Rancho Bernardo Study)

69

Coronary artery calcium volume scores on electron beam tomography in 12,936 asymptomatic adults

70

Coronary Artery Calcium, Carotid Artery Wall Thickness, and Cardiovascular Disease Outcomes in Adults 70 to 99 Years Old

71

Coronary artery calcium, exercise tolerance, and CHD events in asymptomatic men

72

Coronary Artery Complications in Infective Endocarditis

73

Coronary Artery Diameter as a Risk Factor for Acute Coronary Syndromes in Asian-Indians

74

Coronary Artery Diameters in Infants and Children With Congenital Heart Disease as Determined by Computed Tomography

75

Coronary artery dimensions in primary and secondary left ventricular hypertrophy

76

Coronary artery disease after heart transplantation and its relation to cytomegalovirus

77

Coronary Artery Disease and High Altitude: Unresolved Issues

78

Coronary Artery Disease and Its Risk Factors Status in Iran: A Review

79

Coronary artery disease and opioid use

80

Coronary artery disease and plasma apolipoprotein E4 in mild cognitive impairment

81

Coronary Artery Disease in critical patients of Iran

82

Coronary artery disease in diabetic and nondiabetic patients with lower extremity arterial disease: A report from the Coronary Artery Surgery Study Registry, ,

83

Coronary artery disease in diabetic patients: A major therapeutic challenge

84

Coronary artery disease in identical twins

85

Coronary artery disease in identical twins

86

Coronary artery disease in India: challenges and opportunities

87

Coronary artery disease in Iranian overweight women

88

Coronary Artery Disease in Minority Racial and Ethnic Groups in the United States

89

Coronary artery disease in patients at low risk — apolipoprotein AI as an independent risk factor

90

Coronary artery disease in patients undergoing valve replacement at a tertiary care cardiac centre

91

Coronary Artery Disease in patients with chest pain who have low-risk clinical characteristics and negative cardiac troponin I

92

Coronary artery disease in patients with chronic kidney disease: a brief literature review

93

Coronary artery disease in patients with heart failure and preserved systolic function

94

Coronary artery disease in patients with peripheral artery disease

95

Coronary Artery Disease in Patients With Psoriasis Referred for Coronary Angiography

96

Coronary artery disease in patients with type A aortic dissection

97

Coronary artery disease in the developing world

98

Coronary artery disease in the LDL-Apheresis atherosclerosis regression study (LAARS)

99

Coronary artery disease in young adults

100

Coronary Artery Disease in Young: Faulty Life Style or Heredofamilial or Both

101

Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects

102

Coronary artery disease is more than just coronary lumen disease

103

Coronary Artery Disease Presentation and Its Association with Shortened Activated Partial Thromboplastin Time

104

Coronary Artery Disease Prognosis and C-Reactive Protein Levels Improve in Proportion to Percent Lowering of Low-Density Lipoprotein

105

Coronary artery disease progression assessed by electron-beam computed tomography

106

Coronary Artery Disease Progression Late After Successful Stent Implantation

107

Coronary Artery Disease Risk Factors in an Urban and Peri-urban Setting, Kerman, Southeastern Iran (KERCADR Study): Methodology and Preliminary Report

108

CORONARY ARTERY DISEASE RISK FACTORS IN DRIVERS VERSUS PEOPLE IN OTHER OCCUPATIONS

109

Coronary Artery Disease Risk Factors in Patients Undergoing Coronary Artery Bypass Graft Surgery

110

Coronary Artery Disease: A Review of Risk Factors

111

Coronary artery disease: changes of blood lymphocyte subsets induced by physical exercise

112

Coronary artery disease: the folate link

113

Coronary artery disease: the Scandinavian Simvastatin Survival Study Experience

114

Coronary Artery Diseases in Women

115

Coronary artery dissection

116

Coronary artery dissection after blunt chest trauma: Depiction at multidetector-row computed tomography

117

Coronary artery dissection following angioplasty detected by multi-detector row computed tomography: Evaluation using the Plaque Map system

118

Coronary Artery Dissection in a Woman With Previous Systemic Lupus Erythematosus Using Oral Contraceptive Pills

119

Coronary Artery Distensibility Assessed by 3.0 Tesla Coronary Magnetic Resonance Imaging in Subjects With and Without Coronary Artery Disease

120

Coronary artery distensibility in diabetic patients with simultaneous measurements of luminal are and intracoronary pressure : Evidence of impaired reactivity to nitroglycerin

121

Coronary Artery Dominance: What pattern exists in Pakistani Population?

122

Coronary Artery Ectasia in a Patient with Polycystic Kidney Disease

123

Coronary artery ectasia is associated with atrial electrical and mechanical dysfunction: an observational study

124

Coronary Artery Ectasia is Associated with the Elevation of Mean Platelet Volume Regardless of an Existing Acute Coronary Syndrome

125

Coronary Artery Ectasia Presenting as a Non-ST Elevation Myocardial Infarction in a Young Adult: Case Presentation and Literature Review

126

Coronary Artery Ectasia, its Clinical Profile and Angiographic Characteristics, Single Centre Experience

127

Coronary artery ectasia: Is it a destructive inflammatory lesion of the vascular wall?

128

Coronary artery endarterectomy for retrieval of entrapped percutaneous angioplasty catheter

129

Coronary artery endothelial function after myocardial ischemia and reperfusion

130

Coronary artery endothelial protection after local delivery of 17β-estradiol during balloon angioplasty in a porcine model: a potential new pharmacologic approach to improve endothelial function

131

Coronary Artery Erosion and Dissection: An Unusual Complication of Mitral Annular Calcification

132

Coronary Artery Fistula

133

Coronary Artery Fistula and Pectus Excavatum Paradox

134

Coronary Artery Fistula as a Bypass of a Left Anterior Descending Coronary Artery Stenosis

135

Coronary Artery Fistula Diagnosed by Echocardiography during NSTEMI: Case Report and Review of Literature

136

Coronary artery fistula draining into the pulmonary artery

137

Coronary Artery Fistula from Left Circumflex to Coronary

138

Coronary artery fistula in children and adults: a review of 25 cases with long-term observations

139

Coronary artery fistula presented as infective endocarditis with pulmonary septic emboli

140

Coronary Artery Fistula with Double Outlet Right Ventricle: a Case Report

141

Coronary Artery Fistula with Double Outlet Right Ventricle: a Case Report

142

Coronary artery fistula: multidetector row computed tomography angiography in young child

143

Coronary artery fistulae from single coronary artery in a patient with rheumatic mitral stenosis

144

Coronary artery fistulas in infants and children: A surgical review and discussion of coil embolization

145

Coronary artery fistulas presenting with bacterial endocarditis

146

Coronary artery fistulas: Clinical and therapeutic considerations

147

Coronary artery fistulas: long-term results of surgical correction

148

Coronary artery flow measurement using navigator echo gated phase contrast magnetic resonance velocity mapping at 3.0 T

149

Coronary artery flow measurement with magnetic resonance imaging: validation with ultrasound

150

Coronary artery flow ten weeks after myocardial infarction or unstable angina: effects of combined warfarin and aspirin therapy

151

Coronary Artery Hematoma Treated with Fenestration Using a Novel NSE AlphaD Scoring Balloon

152

Coronary artery imaging with multidetector computed tomography: A call for an evidence-based, multidisciplinary approach

153

Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization

154

Coronary artery intimal hyperplasia, occlusive platelet thrombus, and fatal myocardial infarction in an intravenous cocaine user

155

Coronary artery involvement early and late after radiofrequency current application in young pigs, , ,

156

Coronary Artery Involvement Kawasaki Disease Versus Non-Kawasaki Febrile Diseases in Children Attending a Pediatric Hospital in Bandar Abbas

157

Coronary Artery Manifestations of Fibromuscular Dysplasia

158

Coronary artery morphologic features after coronary rotational atherectomy: Insights into mechanisms of lumen enlargement and embolization

159

Coronary artery narrowing after aortic root reconstruction with resorcin-formalin glue

160

Coronary Artery Obstruction After the Arterial Switch Operation for Transposition of the Great Arteries in Newborns

161

Coronary artery obstruction caused by perivalvular abscess in aortic valve endocarditis

162

Coronary artery obstruction due to membranous ridge of the right sinus valsalva associated with Tetralogy of Fallot: syncope mimics anoxic spell

163

Coronary artery operation in patients after breast cancer therapy

164

Coronary Artery Origin Anomalies with Especial Emphasis on Delayed Diagnosis of Anomalous Origin of the Left Coronary Artery from Pulmonary Artery, A report from South of Iran

165

Coronary artery patency following long-term successful engraftment 14 years after bone marrow transplantation in the hurler syndrome

166

Coronary Artery Perforation after Guidewire Removal

167

Coronary artery problems during homograft aortic valve replacement: role of transesophageal echocardiography

168

Coronary artery reconstruction for extensive coronary disease: 108 patients and two year follow-up

169

Coronary Artery Reconstruction: Optimal Technique of Coronary Endarterectomy

170

Coronary artery reoperation through the left thoracotomy with hypothermic circulatory arrest

171

Coronary artery response to cold-pressor test is impaired early after operation in heart transplant recipients

172

Coronary artery restenosis after atherectomy is primarily due to negative remodeling

173

Coronary Artery Revascularization (CARE) Registry: An Observational Study of On-Pump and Off-Pump Coronary Artery Revascularization

174

Coronary Artery Revascularization After Chest Wall Reconstruction With Rectus Abdominis Myocutaneous Flap

175

Coronary Artery Revascularization in a young adult with Solitary Coronary Aneurysm probably secondary to childhood Kawasaki Disease

176

Coronary Artery Revascularization in a Young Adult with Solitary Coronary Aneurysm ProbablySecondary to Childhood Kawasaki Disease

177

Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction

178

Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome

179

Coronary artery spasm and ventricular fibrillation after off-pump coronary surgery Coronary artery spasm and ventricular fibrillation after off-pump coronary surgery

180

Coronary Artery Spasm as a Frequent Cause of Acute Coronary Syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study Original Research Article

181

Coronary Artery Spasm During Dobutamine Stress Echocardiography: A Case Report

182

Coronary Artery Spasm: A Rare But Important Cause of Postoperative Myocardial Infarction

183

Coronary Artery Spatial Distribution, Morphology, and Composition of Nonculprit Coronary Plaques by 64-Slice Computed Tomographic Angiography in Patients With Acute Myocardial Infarction

184

Coronary artery stenoses: A phantom study using contrast enhanced three-dimensional electron beam tomography

185

Coronary artery stenosis morphology and degree of vasomotion in patients with Prinzmetalʹs variant angin

186

Coronary artery stent mimicking intracardiac thrombus on cardiac magnetic resonance imaging due to signal loss: case report

187

Coronary artery stent outcomes in a Medicare population: Less emergency bypass surgery and lower mortality rates in patients with stents, , ,

188

Coronary artery stent placement as a treatment of acute coronary syndrome in course of variant angina

189

Coronary artery stent placement in patients with variant angina refractory to medical treatment

190

Coronary artery stent restenosis responds favorably to repeat interventions

191

Coronary artery stenting in a patient with angina pectoris caused by coronary artery dissection after blunt chest trauma

192

Coronary artery stenting in cardiac allograft vascular disease

193

Coronary artery stenting in the aged

194

Coronary artery stenting in the elderly: short-term outcome and long-term angiographic and clinical follow-up

195

Coronary artery stents

196

Coronary Artery Surgery

197

Coronary artery surgery is associated with different forms of atherogenic lipoprotein modifications

198

Coronary artery to the left atrial fistula after resection of atrial appendages

199

Coronary artery-left ventricular micro-fistulas associated with apical hypertrophic cardiomyopathy

200

Coronary artery-to-left ventricular fistula

201

Coronary atherectomy and thrombectomy

202

Coronary Atheroma Regression and Plaque Characteristics Assessed by Grayscale and Radiofrequency Intravascular Ultrasound After Aerobic Exercise

203

Coronary atherosclerosis and body iron stores

204

Coronary atherosclerosis and oxidative stress as reflected by autoantibodies against oxidized low-density lipoprotein and oxysterols

205

Coronary Atherosclerosis and Quantitative Myocardial Perfusion: A Relationship Beyond Stenosis

206

Coronary atherosclerosis in diabetes mellitus: A population-based autopsy study

207

Coronary atherosclerosis in unheralded sudden coronary death under age 50: histo-pathologic comparison with ‘healthy’ subjects dying out of hospital

208

Coronary Atherosclerosis Is Associated With Macrophage Polarization in Epicardial Adipose Tissue

209

Coronary atherosclerosis stabilization: an achievable goal Original Research Article

210

Coronary Atherosclerosis: Adiponectin and Leptin as Predictors of Disease Severity

211

Coronary atherosclerosis: is the process focal or diffuse among patients with symptomatic or fatal myocardial ischemia?

212

Coronary atherosclerotic lesions in human immunodeficiency virus–infected patients: a histopathologic study

213

Coronary Bifurcation Lesions Treated With Simple Approach (from the Cordoba & Las Palmas [CORPAL] Kiss Trial)

214

Coronary blood flow during reperfusion as an index of the extend of microvascular damage: Experimental study

215

Coronary blood flow dynamics during transcutaneous electrical nerve stimulation for stable angina pectoris associated with severe narrowing of one major coronary artery

216

Coronary Blood Flow in Patients With Severe Aortic Stenosis Before and After Transcatheter Aortic Valve Implantation

217

Coronary blood flow reserve in acute aortic regurgitation

218

Coronary blood flow velocity during apical versus septal pacing

219

Coronary blood flow velocity in normal infants and young adults assessed by transthoracic echocardiography

220

Coronary bypass and carotid endarterectomy: does a combined approach increase risk? A metaanalysis

221

Coronary bypass flow during use of intraaortic balloon pumping and left ventricular assist device

222

Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years

223

Coronary bypass grafting via minithoracotomy on the beating heart

224

Coronary Bypass Grafting Without Use of Cardiopulmonary Bypass for Dextrocardia

225

Coronary Bypass in Women

226

Coronary bypass surgery in women: a long-term comparative study of quality of life after bilateral internal mammary artery grafting in men and women

227

Coronary Calcification and Coronary Artery Disease

228

Coronary calcification and coronary atherosclerosis in asymptomatic persons

229

Coronary Calcification and Coronary Atherosclerosis: Site by Site Comparative Morphologic Study of Electron Beam Computed Tomography and Coronary Angiography

230

Coronary calcification by electron beam computed tomography and obstructive coronary artery disease: model for costs and effectiveness of diagnosis as compared with conventional cardiac testing methods

231

Coronary calcification could predict risk of stroke

232

Coronary calcification is more predictive of carotid intimal medial thickness in black compared to white middle aged men

233

Coronary calcification mimicking the stent: Analysis by MDCT Plaque Map

234

Coronary calcification score and predicted risk of coronary heart disease

235

Coronary calcification score: the coronary-risk impact factor

236

Coronary Calcification, Coronary Disease Risk Factors, C-Reactive Protein, and Atherosclerotic Cardiovascular Disease Events: The St. Francis Heart Study Original Research Article

237

Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain

238

Coronary calcium and cardiovascular event risk: Evaluation by age- and sex-specific quartiles

239

Coronary calcium and standard risk factors in symptomatic patients referred for coronary angiography, ,

240

Coronary calcium as a reliable tool for differentiating ischemic from nonischemic cardiomyopathy

241

Coronary calcium as a risk factor: role in global risk assessment

242

Coronary calcium detected by digital cinefluoroscopy and coronary artery disease in patients undergoing coronary arteriography: effects of age and sex

243

Coronary Calcium Independently Predicts Incident Premature Coronary Heart Disease Over Measured Cardiovascular Risk Factors: Mean Three-Year Outcomes in the Prospective Army Coronary Calcium (PACC) Project Original Research Article

244

Coronary Calcium Predicts Events Better With Absolute Calcium Scores Than Age-Sex-Race/Ethnicity Percentiles: MESA (Multi-Ethnic Study of Atherosclerosis)

245

Coronary Calcium Predicts Myocardial Infarction in Asymptomatic Subjects After Two Years of Follow-up

246

Coronary calcium progression rates with a zero initial score by electron beam tomography

247

Coronary Calcium Remains an Effective Filter for Invasive Angiography

248

Coronary calcium scanning adds incremental value to patients with positive stress tests

249

Coronary Calcium Score Improves Classification of Coronary Heart Disease Risk in the Elderly: The Rotterdam Study

250

Coronary Calcium Scoring: Calcium Location Needs to Be Integrated!

251

Coronary calcium: Is racial profiling necessary?

252

Coronary calcium: The good, the bad, and the uncertain, ,

253

Coronary Circulation Responses to Binodenoson, a Selective Adenosine A2A Receptor Agonist

254

Coronary Collateral Circulation: Effect on Early and Midterm Outcomes After Off-Pump Coronary Artery Bypass Surgery

255

Coronary collateral circulation: The effects of smoking and alcohol

256

Coronary collateral development during chronic ischemia: serial assessment using harmonic myocardial contrast echocardiography

257

Coronary Collateral Function Long After Drug-Eluting Stent Implantation Original Research Article

258

Coronary collateral quantitation in patients with coronary artery disease using intravascular flow velocity or pressure measurements

259

Coronary collaterals in patients with normal and impaired left ventricular systolic function

260

Coronary collaterals, stenoses, and stents: Is a new era of physiologic-guided percutaneous revascularization emerging?

261

Coronary collaterals: The role of MCP-1 during the early phase of acute myocardial infarction

262

Coronary collaterals—insights in molecular determinants and prognostic relevance

263

Coronary Collaterals—Too Small to Be Eyeballed, Too Large to Be Meaningless

264

Coronary Complications of Kawasaki Disease: Novel Diagnosis Based on Z-score and Absolute Dimension

265

Coronary Computed Tomographic Angiographic Findings in Asymptomatic Patients With Heterozygous Familial Hypercholesterolemia and Null Allele Low-Density Lipoprotein Receptor Mutations

266

Coronary Computed Tomographic Angiographic Findings in Asymptomatic Patients With Type 2 Diabetes Mellitus

267

Coronary Computed Tomographic Angiographic Findings in Patients With Kawasaki Disease

268

Coronary Computed Tomographic Angiography as a Gatekeeper to Invasive Diagnostic and Surgical Procedures: Results From the Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) Registry

269

Coronary Computed Tomographic Angiography for Prediction of Procedural and Intermediate Outcome of Bypass Grafting to Left Anterior Descending Artery Occlusion With Failed Visualization on Conventional Angiography

270

Coronary Computed Tomography Angiography After Stress Testing

271

Coronary Computed Tomography Angiography After Stress Testing: Results From a Multicenter, Statewide Registry, ACIC (Advanced Cardiovascular Imaging Consortium)

272

Coronary Computed Tomography Angiography as a Screening Tool for the Detection of Occult Coronary Artery Disease in Asymptomatic Individuals Original Research Article

273

Coronary Computed Tomography Angiography for Early Triage of Patients With Acute Chest Pain: The ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) Trial

274

Coronary computed tomography angiography in a patient with atrial fibrillation, case report

275

Coronary Computed Tomography Angiography in the Emergency Department: The High Stakes Game of Low Risk Chest Pain

276

Coronary Computed Tomography Angiography Versus Coronary Calcium Computed Tomography for Prognosis With Regard to Mortality

277

Coronary Computed Tomography Angiography for the Detection of Cardiac Allograft Vasculopathy: A Meta-Analysis of Prospective Trials

278

Coronary Computed Tomography Angiography: CONFIRMations and Perspectives

279

Coronary Computed Tomography Angiography: Is it Time to Replace the Conventional Coronary Angiogram in Heart Transplant Patients?

280

Coronary Computed Tomography Angiography: Our Time Has Come, But There Are Miles to Go Before We Sleep

281

Coronary Computed Tomography Angiography: The Challenge of Coronary Calcium

282

Coronary Connector Devices: Analysis of 1,469 Anastomoses in 1,216 Patients

283

Coronary constriction in constrictive pericarditis

284

Coronary C-reactive protein distribution: its relation to development of atherosclerosis

285

Coronary CT Angiography Again Results in Better Patient Outcomes

286

Coronary CT Angiography and Dual-Energy Computed Tomography in Ischemic Heart Disease Suspected Patients

287

Coronary cyclic flow variations following primary angioplasty is associated with poor short-term prognosis

288

Coronary Diameter and Vasodilator Function in Children Following Arterial Switch Operation for Complete Transposition of the Great Arteries

289

Coronary Dilator Reserve and Morphological Changes After Relief of Pressure-overload in Rats

290

Coronary disease––prone behavior among Japanese men: Job-centered lifestyle and social dominance, ,

291

Coronary dissection and thrombosis after ingestion of ephedra

292

Coronary dominance and prognosis of patients with acute coronary syndrome

293

Coronary Doppler intensity changes during handgrip: new method to detect coronary vasomotor tone in coronary artery disease

294

Coronary drug-eluting stent development: Issues in trial design

295

Coronary echocardiography in tetralogy of Fallot: diagnostic accuracy, resource utilization and surgical implications over 13 years

296

Coronary Ectasia Is Associated with Impaired Left Ventricular Myocardial Performance in Patients without Significant Coronary Artery Stenosis

297

Coronary Emboli in a Young Patient with Mechanical Aortic Valve: A Rare Cause of Acute Myocardial Infarction

298

Coronary Embolism and Myocardial Infarction in a Transgender Male Undergoing Hormone Therapy: A Case Report and Review of the Literature

299

Coronary Embolism and Subsequent Myocardial Abscess Complicating Ventricular Aneurysm and Tachycardia

300

Coronary embolism causing myocardial infarction in a patient with mechanical aortic valve prosthesis

301

Coronary embolism complicating an atrial myxoma

302

Coronary embolism complicating aortic valve endocarditis: Treatment with successful coronary angioplasty

303

Coronary Embolization in Bullet Wounds: Role of Perioperative Coronary Angiography

304

Coronary embolization of a proximal vessel due to retrieval of a balloon catheter with an organized thrombus during primary PCI

305

Coronary embolus secondary to a prosthetic mitral valve and subtherapeutic anticoagulation

306

Coronary endarterectomy and stent removal after iatrogenic perforation

307

Coronary Endarterectomy and Stent Removal in Patients With In-Stent restenosis

308

Coronary endarterectomy with off-pump coronary artery bypass surgery

309

Coronary Endarterectomy: Impact on Morbidity and Mortality When Combined With Coronary Artery Bypass Surgery

310

Coronary Endarterectomy: The Choice of Tactics is Dictated by the Lay of the Land

311

Coronary endothelial dysfunction after Kawasaki disease

312

Coronary Endothelial Dysfunction After Kawasaki Disease: Evaluation by Intracoronary Injection of Acetylcholine

313

Coronary endothelial dysfunction and hyperlipidemia are independently associated with diastolic dysfunction in humans

314

Coronary endothelial dysfunction and inflammation of coronary atherosclerosis

315

Coronary endothelial dysfunction and myocardial cell damage in chronic stable idiopathic dilated cardiomyopathy

316

Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy

317

Coronary endothelial dysfunction in the early months after heart transplantation

318

Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress

319

Coronary endothelial dysfunction is not rapidly reversible with ascorbic acid

320

Coronary Endothelial Dysfunction Precedes Heart Failure and Reduction of Coronary Reserve in Awake Dogs

321

Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease

322

Coronary endothelial injury after local occlusion on the human beating heart

323

Coronary Endothelial Vasomotor Function and Vascular Remodeling in Heart Transplant Recipients Randomized for Tacrolimus or Cyclosporine Immunosuppression Original Research Article

324

Coronary endothelium expresses a pathologic gene pattern compared to aortic endothelium: Correlation of asynchronous hemodynamics and pathology in vivo

325

Coronary end-to-side sleeve anastomosis using adhesive in off-pump bypass grafting in the pig

326

Coronary events and coronary care: MONICA project

327

Coronary events and coronary care: MONICA project

328

Coronary events and coronary care: MONICA project

329

Coronary events and coronary care: MONICA project

330

Coronary fistula between the left anterior descending coronary artery and the pulmonary artery: Two case reports

331

Coronary Flow Assessment in Unstable Angina/non ST-segment Elevation Myocardial Infarction Patients via Thrombolysis in Myocardial Infarction Frame Count in Angiography

332

Coronary Flow Dynamics Measured by Computed Tomography Angiography

333

Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries

334

Coronary flow reserve and brachial artery reactivity in patients with chest pain and “false positive” exercise-induced ST-segment depression

335

Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension

336

Coronary Flow Reserve Assessed by Transesophageal Echocardiography Identifies Early Restenosis of the Left Anterior Descending Coronary Artery Angioplasty

337

Coronary flow reserve assessment by dobutamine transesophageal doppler echocardiography

338

Coronary flow reserve assessment by dobutamine transesophageal doppler echocardiography

339

Coronary flow reserve assessment from average peak velocity profiles alone must be judged with caution

340

Coronary Flow Reserve Before and After Coronary Artery Bypass Surgery

341

Coronary flow reserve does not adequately interrogate coronary microvascualr function

342

Coronary Flow Reserve During Coronary Angioplasty in Patients With Recent Myocardial Infarction: Relation to Stenosis and Myocardial Viability

343

Coronary flow reserve impairment predicts cardiac events in heart transplant patients with preserved left ventricular function

344

Coronary flow reserve improves after aortic valve replacement for aortic stenosis: an adenosine transthoracic echocardiography study

345

Coronary flow reserve in composite arterial Y grafts

346

Coronary Flow Reserve in Hypertensive Patients With Hypercholesterolemia and Without Coronary Heart Disease

347

Coronary Flow Reserve in the Left Anterior Descending Artery Patients, Diagnostic and Prognostic Value of Doppler Echocardiogrphy

348

Coronary flow reserve is also impaired in patients with subclinical hypothyroidism

349

Coronary flow reserve is impaired in patients with aortic valve calcification

350

Coronary flow reserve is impaired in patients with slow coronary flow

351

Coronary Flow Reserve Is Impaired in Young Men With Familial Hypercholesterolemi

352

Coronary flow reserve may predict myocardial recovery after myocardial infarction in patients with TIMI grade 3 flow, ,

353

Coronary flow reserve measurement in the coronary sinus in pre and post CABG status

354

Coronary flow reserve of the angiographically normal left anterior descending coronary artery in patients with remote coronary artery disease

355

Coronary flow reserve or brachial artery flow to assess endothelial dysfunction: is it time to look at the heart again?

356

Coronary Flow Reserve With a Turbo: A Warning for the Use of Adenosine as a Provocative Test in Patients Receiving Ticagrelor?

357

Coronary flow studies for risk stratification in multivessel disease: A physiologic bridge too far?

358

Coronary flow velocity changes after intravenous dipyridamole infusion: Measurements using intravascular Doppler guide wire documentation of flow inhomogeneity

359

Coronary flow velocity immediately after primary coronary stenting as a predictor of ventricular wall motion recovery in acute myocardial infarction

360

Coronary flow velocity reserve and indices describing aortic distensibility in patients after coronary angiography

361

Coronary flow velocity reserve does not correlate with TIMI frame count in patients undergoing non-emergency percutaneous coronary intervention Original Research Article

362

Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease : Results from the pilot phase of the Women’s Ischemi Syndrome Evaluation (WISE) Study

363

Coronary flow, VO2 peak and anaerobic threshold in patients with dilated cardiomyopathy

364

Coronary flow: how far can we go with echocardiography?

365

Coronary Flow: The Holy Grail of Echocardiography?

366

Coronary grafting using a temporary intraluminal shunt instead of heart-lung bypass

367

Coronary Health Improvement Project (CHIP) is associated with improved nutrient intake and decreased depression

368

Coronary heart disease and associated risk factors in Qazvin: a population-based study

369

Coronary heart disease and chlamydia pneumoniae DNA in blood mononuclear cells

370

Coronary heart disease and lipid-modifying treatment in african american patients

371

Coronary heart disease and vitamin E

372

Coronary heart disease deaths and infarctions in people with little or no coronary calcium

373

Coronary heart disease in Chile

374

Coronary heart disease in Indian Asians

375

Coronary heart disease in Indian Asians

376

Coronary Heart Disease in Patients With Diabetes: Part I: Recent Advances in Prevention and Noninvasive Management Review Article

377

Coronary Heart Disease in Patients With Diabetes: Part II: Recent Advances in Coronary Revascularization Review Article

378

Coronary heart disease in people of south-Asian origin

379

Coronary heart disease in seven countries

380

Coronary heart disease in South Asia: Need to redefine risk

381

Coronary heart disease inequalities: deaths and the socio-economic environment in Nottingham, England

382

Coronary heart disease is a multifactorial disease

383

Coronary heart disease mortality among Arab and Jewish residents of Jerusalem

384

Coronary Heart Disease Mortality Among Young Adults in the U.S. From 1980 Through 2002: Concealed Leveling of Mortality Rates Original Research Article

385

Coronary heart disease mortality and sudden death among the 35–44-year age group in Allegheny County, Pennsylvania

386

Coronary heart disease mortality for six ethnic groups in California, 1990–2000

387

Coronary heart disease mortality, plasma homocysteine, and B-vitamins: a prospective study

388

Coronary heart disease risk factors and menopause: a study in 1684 French women Original Research Article

389

Coronary heart disease risk factors in urban bus drivers

390

Coronary heart disease risk-factor profile in a lower middles class urban community in Pakistan

391

Coronary heart disease still dropping in UK

392

CORONARY HEART DISEASE TOGETHER WITH DIABETES POSES A SERIOUS HEALTH THREAT

393

Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: Meta-analyses of prospective studies, , ,

394

Coronary heart disease, shared care, and cholesterol

395

Coronary heart disease, stroke, and hypertension in a U.S. National cohort: The NHANES I Epidemiologic Follow-up Study

396

Coronary heart disease, type 2 diabetes mellitus and cardiovascular disease risk factors: a study on a middle-aged and elderly population

397

Coronary heart disease: Intervention for intimate relationship issues Original Research Article

398

Coronary Heart Disease: Pandemic in a True Sense

399

Coronary heart disease: where have we been and where are we going?

400

Coronary heart disease:: At the interface of molecular genetics and preventive medicine

401

Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon

402

Coronary hemodynamics in patients with symptomatic hypertrophic cardiomyopathy

403

Coronary hemodynamics of stent implantation after suboptimal and optimal balloon angioplasty

404

Coronary hybrid revascularization from January 1997 to January 2001: a clinical follow-up

405

Coronary in-stent restenosis following beta brachytherapy A histopathological examination

406

Coronary in-stent restenosis: Current status and future strategies

407

Coronary Insufficiency After Stentless Aortic Root Replacement: Risk Factors and Solutions

408

Coronary insufficiency in children: Review of literature and report of a rare case with unknown aetiology

409

Coronary intervention at hospitals without on-site cardiac surgery: are we pushing the envelope too far?

410

Coronary Intervention Without a Safety Net

411

Coronary Intervention, Restenosis and Complications

412

Coronary interventional procedures in pediatric heart transplant recipients with cardiac allograft vasculopathy

413

Coronary interventions: clinical outcomes and non-stent techniques

414

Coronary interventions: keeping score

415

Coronary intravascular ultrasound: implications for understanding the development and potential regression of atherosclerosis

416

Coronary involvement in Takayasuʹs arteritis

417

Coronary ischemia and percutaneous intervention

418

Coronary ischemia induced Wolf Parkinson White syndrome

419

Coronary ischemic disease, arterial stiffness, and pulse pressure

420

Coronary Ischemic Events after First Atrial Fibrillation: Risk and Survival

421

Coronary lesions at increased risk

422

Coronary lumen at six-month follow-up of a new radiopaque cordis tantalum stent using quantitative angiography and intracoronary ultrasound

423

Coronary Magnetic Resonance Imaging: Coming of Age

424

Coronary malperfusion due to type a aortic dissection: mechanism and surgical management

425

Coronary microcirculation evaluation with transesophageal echocardiography Doppler in type II diabetics

426

Coronary microcirculation: Physiology and mechanics

427

Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina

428

Coronary microembolization

429

Coronary microembolization

430

Coronary Microembolization: the Role of TNF- α in Contractile Dysfunction

431

Coronary microvascular abnormalities in Chagasʹ disease

432

Coronary microvascular dilation is impaired during cold pressor test in diabetic patients with angiographically normal coronary arteries

433

Coronary Microvascular Dysfunction and Diastolic Load Correlate With Cardiac Troponin T Release Measured by a Highly Sensitive Assay in Patients With Nonischemic Heart Failure

434

Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: Results from the NHLBI WISE study

435

Coronary microvascular endothelial cell growth regulates expression of the gene encoding p22-phox

436

Coronary Microvascular Function and Cortical Pain Processing in Patients With Silent Positive Exercise Testing and Normal Coronary Arteries

437

Coronary microvascular function and myocardial metabolism in patients with dilated cardiomyopathy

438

Coronary microvascular function and myocardial metabolism in the pig model of pacing induced progressive LV dysfunction

439

Coronary Microvascular Reactivity After Ischemic Cold Storage and Reperfusion

440

Coronary Microvascular Reactivity to Adenosine Predicts Adverse Outcome in Women Evaluated for Suspected Ischemia: Results From the National Heart, Lung and Blood Institute WISE (Womenʹs Ischemia Syndrome Evaluation) Study

441

Coronary microvascular response to intracoronary administration of nicorandil

442

Coronary microvascular spasm and angina pectoris

443

Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina

444

Coronary microvascular spasm in patients with vasospastic angina

445

Coronary microvasculature alteration in hypertensive rats. Effect of treatment with a diuretic and an ACE inhibitor

446

Coronary morphologic findings after stent implantation

447

Coronary MRI: More Pretty Pictures or Present-Day Value?

448

Coronary Multidetector Computed Tomography: A New Standard for Preoperative Risk Assessment?

449

Coronary Myocardial Bridges: Pathophysiology and Clinical Relevance

450

Coronary narrowing secondary to compression by pericardial hydatid cyst

451

Coronary no-flow and ventricular tachycardia associated with habitual marijuana use

452

Coronary No-reflow Phenomenon: A Review of Therapeutic Pharmacological Agents

453

Coronary obstruction by a calcific pericardial ring

454

Coronary operations in octogenarians: can we select the patients?

455

Coronary operations in patients with spinal cord injury

456

Coronary ostial enlargement to prevent stenosis after prosthetic aortic valve replacement

457

Coronary ostial patch angioplasty in children

458

Coronary ostial reconstruction

459

Coronary Ostial Stenosis After Aortic Valve Replacement, Revisited

460

Coronary perforation during unprotected left main angioplasty. Management with conservative approach: a case report

461

Coronary perforation managed with covered stent

462

Coronary perfusate composition influences diastolic properties, myocardial water content, and histologic characteristics of the rat left ventricle

463

Coronary perfusion methods during off-pump coronary artery bypass: results of a randomized clinical trial

464

Coronary perfusion pressure during cardiopulmonary resuscitation

465

Coronary plague instability in severe acute respiratory syndrome

466

Coronary plaque as a replacement for age as a risk factor in global risk assessment

467

Coronary Plaque Burden and Cardiovascular Risk Factors: Single-Point Versus Serial Assessment

468

Coronary plaque burden detected by multislice computed tomography after acute myocardial infarction with near-normal coronary arteries by angiography

469

Coronary plaque composition of nonculprit lesions, assessed by in vivo intracoronary ultrasound radio frequency data analysis, is related to clinical presentation

470

Coronary plaque composition, macrophage infiltration and tissue factor content in patients with diabetes mellitus

471

Coronary Plaque Composition: Multifactorial Contribution

472

Coronary plaque injury triggers neutrophil activation in patients with coronary artery disease

473

Coronary plaque morphologic characteristics early and late after heart transplantation: In vivo analysis with intravascular ultrasonography,

474

Coronary plaque regression: role of low density lipoprotein-apheresis

475

Coronary Plaque Rupture and Vessel Remodeling

476

Coronary pseudoaneurysm: An uncommon cause of P.U.O. after a common procedure: An interesting case report

477

Coronary Pseudoaneurysm: An Unreported Complication of Castleman’s Disease

478

Coronary pseudoaneurysms are a known complication of the Bentall wrap-inclusion method of composite valve grafting. We describe two cases to illustrate a straightforward technique for repair and prevention of coronary pseudoaneurysm formation.

479

Coronary pseudo-lesions induced in the left anterior descending and right coronary artery by the angioplasty guide-wire

480

Coronary reactivity to nitroglycerin: Intravascular ultrasound evidence for the importance of plaque distribution

481

Coronary Recanalization by Elective Angioplasty Prevents Ventricular Dilation After Anterior Myocardial Infarction

482

Coronary recanalization in anterior myocardial infarction: The open perforator hypothesis

483

Coronary Reimplantation After Neoaortic Reconstruction Can Yield Better Result in Arterial Switch Operation: Comparison With Open Trap Door Technique

484

Coronary Reimplantatıon After Neoaortic Reconstruction in Arterial Switch Operation

485

Coronary Reimplantation During Jatene Procedure

486

Coronary reimplantation in aortic root replacement: a method to avoid tension

487

Coronary remodeling of proximal and distal stenotic atherosclerotic plaques within the same artery by intravascular ultrasound study

488

Coronary reoperation via small laparotomy using right gastroepiploic artery without CPB

489

Coronary reoperations: recurrence of angina and clinical outcome with and without cardiopulmonary bypass

490

Coronary reperfusion: numerators searching for denominators

491

Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents

492

Coronary restenosis: a new strategy for the future?

493

Coronary restenosis: a review of mechanisms and management

494

Coronary Revascularization and Cardiac Catheterization in the United States: Trends in Racial Differences

495

Coronary revascularization and quality of life

496

Coronary Revascularization Before Noncardiac Vascular Surgery: One More Step Forward in Understanding Its Role

497

Coronary Revascularization for Patients With Diabetes: Updated Data Favor Coronary Artery Bypass Grafting

498

Coronary revascularization in older women and men in the United States: trends in ethnic differences

499

Coronary Revascularization in the Community: A Population-Based Study, 1990 to 2004 Original Research Article

500

Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction

501

Coronary revascularization is under-utilized in medicaid patients with acute myocardial infarction

502

Coronary revascularization of the circumflex

503

Coronary Revascularization Strategies in Patients With Diabetes and Multivessel Coronary Artery Disease: Has the Final Chapter Been Written?

504

Coronary Revascularization Strategy and Outcomes According to Blood Pressure (from the International Verapamil SR-Trandolapril Study [INVEST])

505

Coronary Revascularization Surgery After Myocardial Infarction: Impact of Bypass Surgery on Survival After Thrombolysis

506

Coronary revascularization with arterial conduits collateral to the lower limb

507

Coronary revascularization with or without cardiopulmonary bypass in patients with preoperative nondialysis-dependent renal insufficiency

508

Coronary revascularization without cardiopulmonary bypass in high-risk patients: a route to the future

509

Coronary revascularization without cardiopulmonary bypass in patients with pectus excavatum

510

Coronary Revascularization Without Cardiopulmonary Bypass Versus the Conventional Approach in High-Risk Patients

511

Coronary risk assessment in women

512

Coronary risk assessment in women

513

Coronary risk assessment methods and cholesterol lowering

514

Coronary risk assessment methods and cholesterol lowering

515

Coronary risk assessment methods and cholesterol lowering

516

Coronary risk assessment methods and cholesterol lowering

517

Coronary risk assessment methods and cholesterol lowering

518

Coronary risk assessment methods and cholesterol lowering

519

Coronary risk assessment methods and cholesterol lowering

520

Coronary risk factor status after percutaneous transluminal coronary angioplasty

521

Coronary risk factors and coronary atheroma burden at severely narrowing segments

522

Coronary risk factors and inflammation in patients with coronary artery disease and internal cardioverter defibrillator implants

523

Coronary Risk Factors and Myocardial Perfusion in Asymptomatic Adults: The Multi-Ethnic Study of Atherosclerosis (MESA) Original Research Article

524

Coronary risk factors in Indians

525

Coronary risk factors in patients with early-onset coronary disease and normal coronariography

526

Coronary risk factors in people from the Indian subcontinent

527

Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India

528

Coronary risk factors in women six months after coronary artery bypass grafting

529

Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: The muscatine study

530

Coronary risk reduction through intensive community-based lifestyle intervention: the Coronary Health Improvement Project (CHIP) experience

531

Coronary Risk Stratification, Discrimination, and Reclassification Improvement Based on Quantification of Subclinical Coronary Atherosclerosis: The Heinz Nixdorf Recall Study

532

Coronary rotational ablation for calcific coronary artery stenosis in a young child

533

Coronary ruptured plaque mimicking spontaneous coronary dissection in a young woman

534

Coronary Segmental Responses to Acetylcholine and Bradykinin in Patients With Atherosclerotic Risk Factors

535

Coronary sinus adrenomedullin rises in response to myocardial injury

536

Coronary Sinus and Ascending Aortic Levels of Aldosterone, Angiotensin II, and B-Type Natriuretic Peptide in Patients With Aortic Stenosis and in Patients With Coronary Heart Disease

537

Coronary sinus catheterization via a femoral vein

538

Coronary sinus dilatation is a sign of impaired right ventricular function in patients with heart failure

539

Coronary sinus diverticulum as a cause of resistant posteroseptal pathway ablation

540

Coronary sinus interventions in cardiac surgery, 2nd edition: Edited by Werner Mohl, MD, PhD, Georgetown, Texas, Landes Bioscience, 2000, 224 pp, illustrated, $99.00, ISBN: 1-58706-006-X

541

Coronary Sinus Orifice Atresia With Left Superior Vena Cava in Patients With Univentricular Heart

542

Coronary sinus ostial atresia with persistent left superior vena cava

543

Coronary sinus ostial atresia: A rare associated anomaly that should be remembered in patients undergoing univentricular palliation

544

Coronary sinus pacing mistaken as interventricular septal perforation and subsequent left ventricular pacing by a transvenously introduced pacing electrode

545

Coronary Sinus Reducer Stent for the Treatment of Chronic Refractory Angina Pectoris: A Prospective, Open-Label, Multicenter, Safety Feasibility First-in-Man Study Original Research Article

546

Coronary Sinus Stenting for the Management of Left Ventricular Lead Displacement during Resynchronization Therapy: A Report of Two Cases

547

Coronary sinus thrombosis after cannulation during cardiopulmonary bypass

548

Coronary Slow Flow Phenomenon Clinical Findings and Predictors

549

Coronary slow flow: Benign or ominous?

550

Coronary Slow-Flow Phenomenon or Syndrome Y: A Microvascular Angina Awaiting Recognition

551

Coronary spasm after injection of ondansetron: Case report and review of the literature

552

Coronary spasm and hypersensitivity to amoxicillin: Kounis or not Kounis syndrome?

553

Coronary Stenosis Detection by 16-Slice Computed Tomography in Heart Transplant Patients: Comparison With Conventional Angiography and Impact on Clinical Management Original Research Article

554

Coronary stenosis dilatation induced by L-arginine

555

556

Coronary stent assessment on multidetector computed tomography: Source and predictors of image distortion

557

Coronary Stent Design and New Clinical Trial Insights

558

Coronary Stent Fracture and In-Stent Restenosis at Coronary Computed Tomography

559

Coronary stent fracture and restenosis in the drug-eluting stent era: Do we have clues of management?

560

Coronary stent fracture in a saphenous vein graft to right coronary artery — Successful treatment by the novel use of the Jomed coronary stent graft: Case report and review of the literature

561

Coronary stent grafts covered by a polytetrafluoroethylene membrane

562

Coronary stent implantation changes 3-D vessel geometry and 3-D shear stress distribution

563

Coronary stent implantation in acute myocardial infarction,

564

Coronary stent implantation in patients older than 75 years of age: Clinical profile and initial and long-term (3 years) outcome

565

Coronary stent implantation is superior to balloon angioplasty for chronic coronary occlusions: Six-year clinical follow-up of the GISSOC trial

566

Coronary stent implantation may seal the inflammatory response in patients with acute coronary syndromes

567

Coronary stent occlusion following strenuous exertion: is the risk actual? Is it preventable?

568

Coronary stent occlusion: Thrombus horribilis

569

Coronary Stent Placement in Patients With Acute Myocardial Infarction: Comparison of Clinical and Angiographic Outcome After Randomization to Antiplatelet or Anticoagulant Therapy

570

Coronary Stent Thrombosis in the Current Drug-Eluting Stent Era: Insights From the ERACI III Trial

571

Coronary Stent Thrombosis With Vorapaxar Versus Placebo: Results From the TRA 2°P-TIMI 50 Trial

572

Coronary stenting after rotational atherectomy in diffuse lesions of the small coronary artery: comparison with balloon angioplasty prior to stenting

573

Coronary stenting after unsuccessful emergency angioplasty in acute myocardial infarction: Results in a series of consecutive patients

574

Coronary Stenting and Inflammation

575

Coronary Stenting and Inflammation: Implications for Further Surgical and Medical Treatment

576

Coronary stenting and use of abciximab

577

Coronary stenting during acute myocardial infarction. Results from the stent without coumadin French registry

578

Coronary stenting for transplant coronary artery disease

579

Coronary stenting for treatment of ostial stenoses of native coronary arteries or aortocoronary saphenous venous grafts

580

Coronary stenting in cardiac allograft vasculopathy

581

Coronary stenting in diabetic patients: Results from the ROSETTA registry

582

Coronary stenting in patients undergoing percutaneous transluminal coronary angioplasty during acute myocardial infarction

583

Coronary stenting in the setting of spontaneous coronary artery dissection

584

Coronary stenting of bifurcation lesions using “T” or “reverse Y” configuration with Wiktor stent

585

Coronary stenting of unprotected left main stem stenoses in elderly patients unsuitable for coronary surgery

586

Coronary stenting or percutaneous transluminal coronary angioplasty prior to noncardiac surgery increases adverse perioperative cardiac events: the evidence is mounting

587

Coronary stenting or percutaneous transluminal coronary angioplasty prior to noncardiac surgery increases adverse perioperative cardiac events: the evidence is mounting: Reply

588

Coronary stenting versus balloon angioplasty for acute myocardial infarction: A meta-regression analysis of randomized trials

589

Coronary stenting versus balloon angioplasty in small vessels

590

Coronary stenting versus balloon angioplasty in small vessels: A meta-analysis from 11 randomized studies Original Research Article

591

Coronary stenting with novel stainless steel balloon-expandable stent: Determinants of neointimal formation and changes in arterial geometry after placement in an atherosclerotic model

592

Coronary stenting with angioscopic guidance

593

Coronary stenting with AVE microstents in acute myocardial infarction

594

Coronary stents: A health system perspective, ,

595

Coronary stents: A materials perspective

596

Coronary stents: An industry perspective, ,

597

Coronary stents—open choices for closed arteries

598

Coronary subclavian steal: A recurrent case with notes on detecting the threat potential

599

Coronary Superficial and Spotty Calcium Deposits in Culprit Coronary Lesions of Acute Coronary Syndrome as Determined by Optical Coherence Tomography

600

Coronary surgery in patients with peripheral vascular disease: effect of avoiding cardiopulmonary bypass

601

Coronary Surgery in Patients With Preexisting Chronic Atrial Fibrillation: Early and Midterm Clinical Outcome

602

Coronary surgery with intermittent aortic cross-clamping: a word of caution on the incidence of cerebrovascular accidents: letter 2

603

Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response

604

Coronary syndromes following aspirin withdrawal: A special risk for late stent thrombosis Original Research Article

605

Coronary thrombosis

606

Coronary thrombosis associated with inherited protein S deficiency: A case report

607

Coronary Thrombosis From Large, Nonprotruding, Superficial Calcified Coronary Plaques

608

Coronary Thrombosis without Dissection following Blunt Trauma

609

Coronary to pulmonary artery collaterals in patients with pulmonary atresia and ventricular septal defect

610

Coronary to pulmonary artery fistula detected by transthoracic echocardiography

611

Coronary tracheal collaterals after heart–lung transplant

612

Coronary vascular dysfunction in premenopausal women with diabetes mellitus

613

Coronary Vascular Morphology in Pressure-overload Left Ventricular Hypertrophy

614

Coronary vascular reactivity is abnormal in patients with Chagasʹ heart disease

615

Coronary Vascular Remodeling in Association With Endothelial Dysfunction

616

Coronary vascular reserve is similarly reduced in hypertensive patients without any other coronary risk factors and in normotensive smokers and hypercholesterolemic patients with angiographically normal coronary arteries

617

Coronary vascular responses to short-term cocaine administration in conscious baboons compared with dogs

618

Coronary Vascular Responsiveness to Adenosine Is Impaired Additively by Blockade of Nitric Oxide Synthesis and Sulfonylure

619

Coronary vasoconstriction after coronary angioplasty is attenuated by endothelin a receptor antagonism

620

Coronary vasoconstriction induced by mental stress (simulated public speaking)

621

Coronary Vasoconstrictive Effects of Neuropeptide Y and Their Modulation by the ATP-Sensitive Potassium Channel in Anesthetized Dogs

622

Coronary vasodilation by noninvasive transcutaneous ultrasound: An in vivo canine study

623

Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction

624

Coronary vasodilator reserve: a clue to the explanation of 201Tl redistribution patterns early after successful primary stenting for acute myocardial infarction

625

Coronary vasodilator responses to bradykinin in euglycemic and diabetic rats

626

Coronary vasodilatory capacity and flow reserve are attenuated in normal myocardium supplied by bypass grafts

627

Coronary vasodilatory capacity and flow reserve in normal myocardium supplied by bypass grafts late after surgery

628

Coronary vasomotility and myocardial blood flow early after heart transplantation

629

Coronary Vasomotion After Percutaneous Transluminal Coronary Angioplasty Depends on the Severity of the Culprit Lesion

630

Coronary vasomotion and exercise‑induced adaptations in coronary artery disease patients: A systematic review and meta‑analysis

631

Coronary vasomotion during dynamic exercise: Influence of intravenous and intracoronary nicardipine

632

Coronary vasomotor function in a normotensive, nondiabetic referral population with normal coronary arteriograms

633

Coronary vasomotor reactivity among normotensive african and white american subjects with chest pain

634

Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: Contrasting myocardial blood flow responses to short- and long-term vitamin C administration

635

Coronary Vasospasm and Coronary Atherosclerosis: Do We Have to Choose?

636

Coronary vasospasm and raspberry ketones weight-loss supplement: Is there a connection?

637

Coronary vasospasm as a cause of effort-related myocardial ischemia during low-dose chronic continuous infusion of 5-fluorouracil

638

Coronary vasospasm as a possible cause of elevated cardiac troponin I in patients with acute coronary syndrome and insignificant coronary artery disease

639

Coronary vasospasm due to hypercholinergic crisis: An example of normal coronary arteriogram and myocardial infarction

640

Coronary vasospasm during an adenosine stress test

641

Coronary vasospasm in a patient suffering from sarin poisoning

642

Coronary Vasospasm Induced During Isoproterenol Head-Up Tilt Test

643

Coronary vasospasm secondary to hypercholinergic crisis: An iatrogenic cause of acute myocardial infarction in myasthenia gravis

644

Coronary vasospasm-induced acute coronary syndrome complicated by life-threatening cardiac arrhythmias in patients without hemodynamically significant coronary artery disease

645

Coronary vein balloon angioplasty forleft ventricular pacemaker lead implantation

646

Coronary venous angioplasty to a ring- like stricture preventing left ventricular lead insertion

647

Coronary venous imaging with electron beam computed tomographic angiography: Three-dimensional mapping and relationship with coronary arteries

648

Coronary ventricular fistula as a complication of PTCA: A case report and literature review

649

Coronary vessel trees from 3D imagery: A topological approach

650

Coronary wallstents show significant late, postprocedural expansion despite implantation with adjunct high-pressure balloon inflations

651

Coronary-artery bypass surgery and the brain: persisting concerns

652

Coronary-Artery Stent

653

Coronary-Cameral Fistula Connecting the Left Anterior Descending Artery and the First Obtuse Marginal Artery to the Left Ventricle: A Rare Finding

654

Coronary-cameral fistula in an asymptomatic adult patient

655

Coronary-coronary bypass using the radial artery

656

Coronary-coronary radial artery graft for single, distal LAD lesion

657

Coronary-pulmonary artery fistula: Heart-on-a-heart appearance

658

Coronary-pulmonary fistula serving as a collateral source to the occluded coronary artery in a patient with myocardial infarction

659

Coronary-pulmonary steal syndrome

660

Coronary-Subclavian Steal Syndrome Following CABG: a Case Report and Literature Review

661

Coronary-subclavian steal syndrome in a hemodialysis patient with ipsilateral subclavian artery occlusion and contralateral vertebral artery stenosis “Case Report”

662

Coronary–Subclavian Steal Syndrome: An usual cause of refractory unstable angina

663

Coronary-to-coronary bypass using a free internal mammary artery: An alternative

664

Coronas and iridescence in mountain wave clouds

665

Coronas of balleans

666

CORONAS-F observations of active phenomena on the sun Original Research Article

667

CORONAS-F satellite: Tasks for study of particle acceleration Original Research Article

668

Coronatine alleviates salinity stress in cotton by improving the antioxidative defense system and radical-scavenging activity

669

Coronatine, a more powerful elicitor for inducing taxane biosynthesis in Taxus media cell cultures than methyl jasmonate

670

Coronavirus (COVID-19) and Possibilities for Criminal Law Reaction in Europe: A Review

671

Coronavirus (COVID-19) Infection in Newborns

672

Coronavirus (SARS-CoV-2) Deactivation via Spike Glycoprotein Shielding by Old Drugs: Molecular Docking Approach

673

Coronavirus and Divine Justice and its Relation to the Issue of Natural and Moral Evil

674

Coronavirus and Emergence of an Extraordinary Political Economy: editorial note

675

Coronavirus Anxiety: The Predictive Role of Perfectionism and Self-compassion

676

Coronavirus as a possible cause of severe acute respiratory syndrome

677

Coronavirus confirmed as cause of SARS

678

Coronavirus COVID-19 and its Effect on Erection and Patients’ Sexual Disorders: A Narrative Review

679

Coronavirus Disease (COVID-19) and Dental Treatment

680

Coronavirus Disease (COVID-19): 10 Questions and Discussion Points for Diabetes and COVID-19

681

Coronavirus Disease 19 with Spontaneous Pneumomediastinum: A Report of Three Cases

682

Coronavirus disease 2019 (COVID-19) and cardiovascular events

683

Coronavirus disease 2019 (COVID-19) and pediatric gastroenterology

684

Coronavirus Disease 2019 (COVID-19) in adolescents: An update on current clinical and diagnostic characteristics

685

Coronavirus Disease 2019 (Covid-19) in Middle East: Data, Facts and Doubts

686

Coronavirus disease 2019 (COVID-19) manifestations during pregnancy in all three trimesters: A case series

687

Coronavirus Disease 2019 (COVID-19) Outbreak in Pediatrics and the Role of Pediatricians: A Systematic Review

688

Coronavirus Disease 2019 (COVID-19): A Systematic Review of Pregnancy and the Possibility of Vertical Transmission

689

Coronavirus Disease 2019 (COVID-19): review study

690

Coronavirus Disease 2019- Challenges Today and Tomorrow in Orthodontic Practice: A Review

691

Coronavirus Disease 2019 in Children with Acute Respiratory Infection: A Study From Southeastern Iran

692

Coronavirus Disease 2019 in Patients with Thalassemia; Emerging Challenges

693

Coronavirus Disease 2019 Occupational Considerations for Surgeons: A Review Article

694

Coronavirus Disease 2019 Vaccine Hesitancy in the Kurdistan Region: A Cross-Sectional National Survey

695

Coronavirus disease 2019: Global Contamination and Global Cleanup

696

Coronavirus Disease 2019: Latest Data on Neuroinvasive Potential

697

Coronavirus Disease in Cardiovascular Patients: Clinical Characteristics and Final Prognosis

698

Coronavirus Disease-19 (COVID-19) Presenting with Severe Acute Pancreatitis: A Case Report from Iran

699

Coronavirus Disease-2019 Infection in Neonates of an Infected Pregnant Mother with Triplets

700

Coronavirus in severe acute respiratory syndrome (SARS)

701

Coronavirus Incidence Rate Estimation from Social Media Data in Iran

702

Coronavirus infections in children: from SARS and MERS to COVID-19, a narrative review of epidemiological and clinical features

703

Coronavirus N Protein N-Terminal Domain (NTD) Specifically Binds the Transcriptional Regulatory Sequence (TRS) and Melts TRS-cTRS RNA Duplexes

704

Coronavirus Pandemic and Worries during Pregnancy; a Letter to Editor

705

Coronavirus phylogeny based on triplets of nucleic acids bases

706

Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction due to Attenuated Pathogenicity and Booster Vaccine Doses

707

Coronavirus, Its Neurologic Manifestations, and Complications

708

Coronavirus: Bibliometric analysis of scientific publications from 1968 to 2020

709

Coronavirus: Discover the Structure of Global Knowledge, Hidden Patterns & Emerging Events

710

Coronavirus: Nursing Students’ Knowledge and Risk Perception of Clinical Practice during the Pandemic

711

Coronavirus: Where Has All the Health Economics Gone?

712

Coronaviruses and gastrointestinal symptoms: an old liaison for the new SARS-CoV-2

713

Coronaviruses Pathogens in Human in Third Millennium (SARS-CoV, MERS, COVID-19): A Review Article

714

Coronavirus-induced Anxiety among Pregnant Women

715

Coronavirus-nephropathy; renal involvement in COVID-19

716

Coronavirus-Related Opportunities for Promoting Occupational Health and Safety

717

Coroner autopsies originating from complaints to the police in a Nigerian Urban centre

718

Coroner Wakley: two remarkable eyewitness accounts

719

Coroners and public health

720

Coronilla juncea is both a nutritive fodder shrub and useful in the rehabilitation of abandoned Mediterranean marginal farmland

721

Coronin 1B Antagonizes Cortactin and Remodels Arp2/3-Containing Actin Branches in Lamellipodia

722

Coronin 1B Coordinates Arp2/3 Complex and Cofilin Activities at the Leading Edge

723

Coronin-1A Stabilizes F-Actin by Bridging Adjacent Actin Protomers and Stapling Opposite Strands of the Actin Filament

724

Coronoid systems with perfect matchings Original Research Article

725

Corono-radicular biological restoration of maxillary central incisors by direct method

726

Corosolic acid induces apoptosis through mitochondrial pathway and caspases activation in human cervix adenocarcinoma HeLa cells

727

Corosolic acid induces apoptotic cell death in human lung adenocarcinoma A549 cells in vitro

728

COROT: A minisat for pionnier science, asteroseismology and planets finding Original Research Article

729

CoRoT: Harvest of the exoplanet program

730

Co-rotation constructions of residuated semigroups

731

Corotation resonances and planetary formation

732

Co-rotational beam elements with warping effects in instability problems Original Research Article

733

Co-rotational dynamic analysis of flexible beams Original Research Article

734

Co-rotational finite element formulation for thin-walled beams with generic open section Original Research Article

735

Co-rotational flat facet triangular elements for shell instability analyses Original Research Article

736

Co-rotational formulation for geometric nonlinear analysis of doubly symmetric thin-walled beams Original Research Article

737

Corotational formulation for nonlinear dynamics of beams with arbitrary thin-walled open cross-sections

738

Corotational mixed finite element formulation for thin-walled beams with generic cross-section

739

Corotational non-linear analysis of thin plates and shells using a new shell element

740

Corotational nonlinear dynamic analysis of laminated composite shells

741

CORPORA AMYLACEA IN HUMAN CADAVERIC BRAIN AGE RELATED DIFFERENCES

742

CORPORA IN LANGUAGE RESEARCH IN MALAYSIA

743

Corpora Lutea Diameter, Plasma Progesterone Concentration and Follicular Development in PGF2α and CIDR Estrus Synchronized Goats

744

CORPORA USE IN THE TEACHING OF ENGLISH WRITING

745

Corporal punishment and child adjustment

746

Corporal Punishment and its Effects in Pakistan

747

Corporal punishment and physical maltreatment against children: A community study on Chinese parents in Hong Kong

748

Corporal punishment and primary prevention of physical abuse

749

Corporate "central nervous system" software

750

Corporate and Institutional Transparency for Economic Growth in Europe, Oxelheim Lars (Ed.). Elsevier, Amsterdam (2006) 444p, € 76.99, ISBN 0-08-044665-5.

751

Corporate and social performance links in the gaming industry

752

Corporate asset purchases and sales: Theory and evidence

753

Corporate bankruptcies and official bail-outs: A cost–benefit analysis

754

Corporate behavior and competitiveness: impact of environmental regulation on Chinese firms

755

CORPORATE BLOGS AS ACORPORATECOMMUNICATION STRATEGY

756

Corporate board attributes and bankruptcy

757

Corporate boards and regulation: The effect of the Sarbanes–Oxley Act and the exchange listing requirements on firm value

758

Corporate body name changes: Helping the user search efficiently and effectively

759

Corporate bond default risk: A 150-year perspective

760

Corporate bond liquidity and matrix pricing

761

Corporate bond liquidity before and after the onset of the subprime crisis

762

Corporate bond ratings changes and economic instability: Evidence from the Korean financial crisis

763

Corporate Call Policy for Nonconvertible Bonds

764

Corporate capital structure and the characteristics of suppliers and customers

765

Corporate capital structure in turbulent times: a case study of the US airline industry

766

Corporate capture and Coca-Cola

767

Corporate cash flow and stock price exposures to foreign exchange rate risk

768

Corporate cash holdings and CEO compensation incentives

769

Corporate cash holdings: An empirical investigation of UK companies

770

Corporate Champions: doing good more effectively

771

Corporate characteristics, governance attributes and the extent of voluntary disclosure in Bangladesh

772

Corporate citizenship and public relations: The importance and interactivity of social responsibility issues on corporate websites

773

Corporate citizenship and the employee/citizen solider

774

Corporate comets or typical trajectories?: Corporate dynamics in the 1990s

775

Corporate communications managers in large firms: new challenges

776

Corporate Community Involvement. The Definitive Guide to Maximizing Your Business’ Societal Engagement

777

Corporate contracting for health care

778

Corporate control and enterprise structure in the Canadian economy: 1972–1987

779

Corporate control and industry structure in global communications: an introduction

780

Corporate control and real investment in incomplete markets

781

Corporate control and the market for managerial labour: On the decision to go public

782

Corporate control, bank risk taking, and the health of the banking industry

783

Corporate control, expected underpricing, and the choice of issuance mechanism in unseasoned equity markets

784

Corporate cost of occupational accidents: an activity-based analysis

785

Corporate Credibility’s Role in Consumers’ Attitudes and Purchase Intentions When a High versus a Low Credibility Endorser Is Used in the Ad

786

Corporate credit risk modeling and the macroeconomy

787

CORPORATE CRIME ANNOUNCEMENT EFFECTS ON STOCK PERFORMANCE: AN EMPIRICAL STUDY IN MALAYSIA

788

corporate crime in indonesian criminal law system

789

Corporate Cultural Dimensions, Social Responsibility and Financial Performance

790

Corporate Culture and Commitment: Impact on Performance of International New Product Development Programs

791

Corporate culture and the bottom line

792

Corporate culture, absorptive capacity and IT success

793

Corporate culture, related chief executive officer traits, and the development of executive information systems

794

Corporate debt and output pricing in developing countries: Industry-level evidence from Turkey

795

Corporate Default Prediction among Tehran Stock Exchange’s Selected Industries

796

Corporate derivatives use and firm value: Evidence from Turkey

797

Corporate disclosure quality, earnings smoothing, and earningsʹ timeliness

798

Corporate disclosures made by Chinese listed companies

799

Corporate distress and lobbying: Evidence from the Stimulus Act

800

Corporate diversification and asymmetric information: evidence from stock market trading characteristics

801

Corporate diversification and efficiency of manufacturing firms listed in Bursa Malaysia

802

Corporate diversification and performance: evidence on production efficiency

803

Corporate diversification and shareholder value: a survey of recent literature

804

Corporate diversification strategies and capital structure

805

Corporate diversification, information asymmetry and firm performance: Evidence from Tehran Stock Exchange

806

Corporate Diversification, Value Maximization, and Organizational Capabilities

807

Corporate diversification: identifying new businesses systematically in the diversified firm

808

Corporate diversification’s effects on Efficiency and productivity: case study of Manufacturing firms listed in Bursa Malaysia

809

Corporate dynamic transparency: the new ICT-driven ethics?

810

Corporate earnings and the equity premium

811

Corporate elites as informants in qualitative international business research

812

Corporate enterprise: a new reality for hospitality organisations?

813

Corporate entrepreneurs and privatized firms in russia, ukraine, and belarus

814

Corporate entrepreneurship and financial performance: The case of management leveraged buyouts

815

Corporate entrepreneurship antecedents and performance in agricultural advisory services corporations in west of Iran

816

Corporate entrepreneurship in network organizations:: How subsidiary initiative drives internal market efficiency

817

Corporate Entrepreneurship in Training Institutions

818

Corporate entrepreneurship:: antidote or oxymoron?

819

Corporate environme ntal behavior research: informing environme ntal policy

820

Corporate environmental and resource management: In search of a new managerial paradigm

821

Corporate environmental disclosure, financial markets and the media: An international perspective

822

Corporate environmental disclosures: are they useful in determining environmental performance?

823

Corporate environmental disclosures: Competitive disclosure hypothesis using 1991 annual report data

824

Corporate Environmental Innovation (CEI): a government initiative to support corporate sustainability leadership

825

Corporate Environmental Management 2: Culture and Organisations : , Earthscan Publications Ltd (1997) 192 £15.95. Building to Last: The Challenge for Business Leaders, , Earthscan Publications Ltd (1997) 204 £15.95

826

Corporate environmental management and regulation of mining operations in the Cyclades, Greece

827

Corporate environmental market responsiveness: A model of individual and organizational drivers

828

Corporate environmental responsibility in the supply chain

829

Corporate environmental responsiveness in India: lessons from a developing country

830

Corporate environmental strategy: The avalanche of change since Bhopal : B.W. Piasecki (author) John Wiley & Sons, 1995, 180 pp, ISBN 0-471-10627-5, US$24.95

831

Corporate environmentalism: the construct and its measurement

832

CORPORATE EQUAL OPPORTUNITIES (NON-) DISCLOSURE

833

Corporate ergonomics programme at automobiles Peugeot-Sochaux

834

Corporate ergonomics programme at BCM Airdrie

835

Corporate ergonomics programme at Ford Motor Company

836

Corporate ergonomics programme at Scottish & Newcastle

837

Corporate ergonomics programme at Volvo Car Corporation

838

Corporate Excellence in the Year 2000 : L K T , Century (1996), 350 pp., £18.99

839

Corporate Farm Performance in Russia, 1991–1995: An Efficiency Analysis

840

Corporate finance and state enterprise reform in China

841

Corporate finance—Theory and practice

842

Corporate Financial Accounting and Reporting: by Tim Sutton, Financial Times/Prentice Hall, Harlow, Essex, England, 2000, xiii+754 pp

843

Corporate financial decision-makers’ perceptions of workplace safety

844

Corporate financial disclosure in emerging markets: Does economic development matter?

845

CORPORATE FINANCIAL MANAGEMENT: TIME TO CHANGE THE “COST OF CAPITAL” PARADIGM?

846

Corporate Financial Reporting. Theory and Practice: Andrew Higson (Ed.); Sage, 2003, 228 pages, ISBN 0-7619-7141-6 (£24.99)

847

Corporate Financial Reporting: A Global Perspective: by Hervé Stolowy and Michel J. Lebas, Thomson, London, UK, 2002, xxvi+636 pp. ISBN: 1-861-52753-5, £31.99

848

Corporate Financial Reporting: By Bhabatosh Banerjee and Arun Kumar Basu (Eds.), University of Calcutta, Calcutta, 2001, vi+275 pages

849

Corporate Financial Strategies for Global Competitiveness

850

Corporate Financing and Goverance in Japan: The Road to the Future: by Takeo Hoshi and Anil Kashyap, MIT Press, 2002.

851

Corporate financing decisions when investors take the path of least resistance

852

Corporate financing decisions, managerial market timing, and real investment

853

Corporate firms in the 21st century: A note.

854

Corporate focus and stock returns,

855

Corporate focus and value creation evidence from spinoffs

856

Corporate focus versus diversification: the role of growth opportunities and cashflow

857

Corporate fraud, systematic risk, and shareholder enrichment

858

Corporate futures: social responsibility in the tourism industry: Angela Kalisch; Tourism Concern, London, 2002, 47pp, price £15 (£10 for members), ISBN 0-9528567-7-8

859

Corporate goodness and shareholder wealth

860

CORPORATE GOVERNANCE AND ACCOUNTING MODELS OF THE REPORTING ENTITY,

861

Corporate governance and accounting systems: a critical perspective

862

Corporate Governance and Audit Fees: Evidence from a Developing Country

863

Corporate Governance and Audit Opinion Shopping: Evidence from Iran

864

Corporate governance and audit report lag in Malaysia

865

Corporate governance and bank performance: A joint analysis of the static, selection, and dynamic effects of domestic, foreign, and state ownership

866

Corporate governance and board effectiveness

867

Corporate Governance and Corporate Social Responsibility: The Case of Small, Medium, and Large Firms

868

Corporate Governance and Credit Risk in the Iranian Banking Industry

869

Corporate governance and dividend pay-out policy in Germany

870

Corporate governance and dividend policy in emerging markets

871

Corporate governance and dividend policy: A comparison of Chinese firms listed in Hong Kong and in the Mainland

872

Corporate governance and earnings management in the Chinese listed companies: A tunneling perspective

873

Corporate Governance and Employee Ownership in an Economic Crisis: Enterprise Strategies in the Former USSR

874

Corporate governance and executive compensation

875

Corporate governance and firm cash holdings in the US

876

Corporate governance and firm performance: Evidence from Japanese manufacturing industries after the lost decade

877

Corporate governance and firm profitability: evidence from Korea before the economic crisis

878

Corporate governance and firm valuation

879

Corporate governance and firm value: evidence from the Korean financial crisis

880

Corporate governance and firm value\In Japan: Evidence from 1985 to 199

881

Corporate governance and globalization. Long range planning issues: Stephen S. Cohen & Gavin Boyd (Eds); Edward Elgar Publishing, Cheltenham, UK, 2000, pp. 373

882

Corporate governance and information asymmetry

883

Corporate governance and innovation: The UK compared with the US and ‘insider’ economies

884

CORPORATE GOVERNANCE AND INSTITUTIONAL INVESTORS: EVIDENCE FROM MALAYSIA

885

Corporate governance and intellectual capital

886

Corporate Governance and Investment Decisions in Deposit Money Banks in Nigeria

887

Corporate governance and investment in Central and Eastern Europe

888

Corporate governance and investment in East Asian firms—empirical analysis of family-controlled firms

889

Corporate Governance and Iranian Banking Economic Value Added

890

Corporate Governance and Liquidity Creation: Evidence from Iranian Banks

891

Corporate Governance and Liquidity Management: Evidence from Nigerian Deposit Money Banks

892

Corporate governance and lobbying strategies

893

Corporate governance and manager turnover: An unusual social experiment

894

Corporate governance and market valuation in China

895

Corporate governance and market valuation of capital and R&D investments

896

Corporate governance and mass privatisation: A theoretical investigation of transformations in legal and economic relationships

897

Corporate governance and merger performance: Learning from the Australian experience

898

Corporate governance and ownership structure of target companies and the outcome of takeovers

899

Corporate governance and pay-for-performance: The impact of earnings management

900

Corporate governance and performance of small high-tech firms in Sweden

901

Corporate governance and profit manipulation: a French field study

902

CORPORATE GOVERNANCE an‎d PUBLIC RELATIONS: A QUALITATIVE RESEARCH WITH PUBLIC RELATIONS EXPERTS

903

Corporate Governance and R D Reporting in Malaysian MESDAQ Market

904

Corporate governance and recent consolidation in the banking industry

905

CORPORATE GOVERNANCE AND ROLE OF CEO IN ENGINEERING COMPANIES

906

Corporate governance and shareholder initiatives: Empirical evidence

907

Corporate governance and shareholder patience

908

Corporate governance and state-owned shares in China listed companies

909

Corporate governance and the quality of financial analysts’ information

910

Corporate governance and the spinoff decision

911

Corporate governance and the value of cash holdings

912

Corporate governance and voluntary disclosure

913

Corporate Governance and Voluntary Disclosure Practices: Evidence from a Two Tier Board Systems in Indonesia

914

Corporate governance assessment in company board structure

915

Corporate governance attributes, firm characteristics and the level of corporate disclosure: Evidence from the Indian listed firms

916

Corporate Governance Characteristics and Company Performance

917

Corporate Governance Characteristics and Discretionary Accruals Among Non-Financial Firms Listed in Nairobi Securities Exchange

918

Corporate governance digest

919

Corporate governance effectiveness during institutional transitio

920

Corporate governance in China: An overview

921

Corporate governance in china: Explosive growth and new patterns of ownership

922

Corporate Governance in Insurance Sector and The Impact of Corporate Governance Committee

923

Corporate Governance in Russia:: towards a European, US, or Russian Model?

924

Corporate governance in South Korea: the chaebol experience

925

Corporate governance in the Asian countries

926

Corporate governance in the Asian financial crisis

927

CORPORATE GOVERNANCE IN THE CONTEXT OF CORPORATE SUSTAINABILITY: THE BIRTH, THE DEVELOPMENT an‎d THE EVALUATION OF THE CONCEPT

928

Corporate governance in the deregulated telecommunications industry: lessons from the airline industry

929

Corporate Governance in the Former Soviet Union

930

Corporate Governance in the Former Soviet Union: An Overview

931

Corporate Governance In Turkey: An Overview

932

Corporate governance indices and firmsʹ market values: Time series evidence from Russia

933

Corporate governance issues and director compensation structure in Spanish companies

934

Corporate Governance Mechanisms and Financial Performance: Evidence from the Listed Bank in Bangladesh

935

Corporate governance of Japanese banks

936

Corporate governance over the business cycle

937

Corporate Governance Perspectives for Zimbabwean SMEs

938

Corporate governance post-Enron: Effective reforms, or closing the stable door?

939

Corporate Governance Practices and Environmental Reporting of Companies in Malaysia: Finding Possibilities of Double Thumbs Up

940

Corporate Governance Practices in Bangladesh: A Comparative Analysis between Conventional Banks and Islamic Banks

941

Corporate governance practices, CEO characteristics and firm performance

942

Corporate governance proposals and shareholder activism: the role of institutional investors

943

Corporate governance provisions and firm ownership: Firm-level evidence from Eastern Europe

944

Corporate Governance Quality :A Literature Review

945

Corporate Governance Structure, Legal Environment, and Valuation

946

Corporate governance when founders are directors

947

Corporate Governance with the Institutional Theory Approach on Regional Development Banks in Indonesia

948

Corporate Governance, Accountability, and Pressures to Perform: An International Study: by Istemi S. Demirag, JAI Press, Stamford, CT, 1998, xv+395 pp.

949

Corporate governance, bank specific characteristics, banking industry characteristics, and Intellectual Capital (IC) performance of banks in Arab Gulf Cooperation Council (GCC) countries

950

Corporate governance, chief executive officer compensation, and firm performance

951

Corporate governance, competition policy and industrial policy

952

Corporate governance, corporate social responsibility and corporate risk: Evidence on Indonesia

953

Corporate governance, dividend payout policy, and the interrelation between dividends, R&D, and capital investment

954

Corporate Governance, Executive Directors and Level of Voluntary Disclosure: The Case of Public Listed Companies in Thailand

955

Corporate governance, investor protection, and performance in emerging markets

956

Corporate governance, ownership dispersion and efficiency: Empirical evidence from Austrian cooperative banking

957

Corporate governance, Sarbanes-Oxley, and small-cap firm performance

958

Corporate governance, shareholder rights and firm diversification: An empirical analysis

959

Corporate governance, strategic philanthropy, and public policy

960

Corporate governance, top executive compensation and firm performance\In Japan

961

Corporate governance, tourism growth and firm performance: Evidence from publicly listed tourism firms in five Middle Eastern countries

962

Corporate governance: Accountability, enterprise and international comparisons, 2005

963

Corporate Governance: Board Structure, Information Technology and CSR Reporting

964

CORPORATE GOVERNANCE: CAN CREDITORS FIT IN WITH COMPANIES’ BOARD OF DIRECTORS?

965

Corporate governance: Kenneth A. Kim, John R. Nofsinger; Pearson Education Inc., 94 pages, ISBN 0131423878, £19.99

966

CORPORATE GOVERNANCE: NOMINEE DIRECTOR THE GATEKEEPER

967

CORPORATE GOVERNANCE: OVERVIEW AND RESEARCH AGENDA

968

Corporate Governance: SMEs Experience in Metro Cebu, Philippines

969

Corporate Governance: Theory and Some Insights into the Malaysian Practices

970

Corporate governance\In New Zealand: The effect of the 1993 Companies Act on the relation between board composition and firm performance

971

Corporate government digest

972

Corporate groups, dual-class shares and the value of voting rights

973

Corporate Harm Minimisation: Promises and Perils; Comment on “Understanding Marketing Responses to a Tax on Sugary Drinks: A Qualitative Interview Study in the United Kingdom, 2019”

974

Corporate heritage identity management and the multi-modal implementation of a corporate heritage identity

975

Corporate identity: The role of mission statements

976

Corporate image and corporate reputation in customers’ retention decisions in services

977

Corporate image of zakat institutions in Malaysia

978

Corporate imagesʹ impact on consumersʹ product choices: The case of multinational foreign subsidiaries

979

Corporate Inertia and Information Asymmetry: Evidence from Iran

980

Corporate Information Protection Program: Concept of Operations

981

Corporate initiatives in ergonomics—an introduction

982

Corporate Insurance and Managerial Incentives

983

Corporate integration and market liberalisation in the EU

984

Corporate Integrity and Information Asymmetry: Evidence from Iran.

985

Corporate intelligence dissemination as a consequence of intranet effectiveness: an empirical study

986

Corporate international activities and cash holdings

987

Corporate Internet Reporting in Emerging Economic Countries: The Malaysian Perspective

988

Corporate investment and financing under asymmetric information

989

Corporate investment myopia: a horserace of the theories

990

Corporate investment, financing, and dividend policies in the high-tech industry

991

Corporate Killing For Malaysia: A Preliminary Consideration

992

Corporate knowledge transfer via interlocking directorates: a network analysis approach

993

Corporate Leadership: Reflections of a CEO and CEO Advisor

994

Corporate learning: A knowledge management perspective

995

Corporate leverage and currency crises

996

Corporate life cycle and share repurchases: Evidence from the Taiwan Stock Market

997

Corporate lobbying in the UK: an analysis of attitudes towards the ASBʹs 1995 deferred taxation proposals

998

CORPORATE MAKAHIKI: THE GOVERNING TELOS OF PEACE

999

Corporate management of the Northwestern Hawaiian Islands lobster fishery

1000

Corporate mandatory disclosure practices in Bangladesh

بازگشت